Kraft, M., Büscher, A., Wiedmann, F., L’hoste, Y., Haefeli, W. E., Frey, N., . . . Schmidt, C. (2021). Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option. Front Pharmacol.
Citação norma ChicagoKraft, Manuel, Antonius Büscher, Felix Wiedmann, Yannick L’hoste, Walter E. Haefeli, Norbert Frey, Hugo A. Katus, and Constanze Schmidt. "Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition As an Emerging Novel Therapy Option." Front Pharmacol 2021.
Citação norma MLAKraft, Manuel, et al. "Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition As an Emerging Novel Therapy Option." Front Pharmacol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.